Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-17

Clinical Trial Update: Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reporting safety and efficacy results for sitagliptin in adults with Type 2 Diabetes; the study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2010-06-17